Yield10 Bioscience, Inc. (YTEN)
NASDAQ: YTEN · IEX Real-Time Price · USD
0.222
-0.017 (-7.20%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Yield10 Bioscience Stock Forecast
YTEN's stock price has decreased by -92.35% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Yield10 Bioscience stock have an average target of 2.25, with a low estimate of 0.50 and a high estimate of 4.00. The average target predicts an increase of 914.43% from the current stock price of 0.22.
Analyst Consensus: Buy
* Price targets were last updated on Feb 8, 2024.
Analyst Ratings
The average analyst rating for YTEN stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $0.5 | Strong Buy → Hold | Downgrades | $0.5 | +125.43% | Feb 8, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +1,703.43% | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $4 | Strong Buy | Maintains | $25 → $4 | +1,703.43% | Aug 17, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $12 → $3 | Strong Buy | Maintains | $12 → $3 | +1,252.57% | Aug 16, 2023 |
Financial Forecast
Revenue This Year
2.30M
from 60.00K
Increased by 3,725.00%
Revenue Next Year
4.08M
from 2.30M
Increased by 77.78%
EPS This Year
-0.77
from -1.82
EPS Next Year
-0.87
from -0.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.2M | 4.2M | 28.1M | 49.5M | 74.3M |
| Avg | 2.3M | 4.1M | 27.3M | 48.1M | 72.1M |
| Low | 1.5M | 3.9M | 26.2M | 46.2M | 69.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5,150.0% | 83.0% | 588.4% | 81.4% | 54.4% |
| Avg | 3,725.0% | 77.8% | 568.8% | 76.3% | 50.0% |
| Low | 2,350.0% | 70.8% | 542.5% | 69.3% | 44.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.65 | -0.89 | -0.15 | 0.05 | 0.23 |
| Avg | -0.77 | -0.87 | -0.14 | 0.05 | 0.22 |
| Low | -0.87 | -0.83 | -0.14 | 0.05 | 0.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 352.9% |
| Avg | - | - | - | - | 340.0% |
| Low | - | - | - | - | 322.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.